Besides, CPT1A methylation is associated with circulating adiponectin levels, likely in an obesity-dependent manner, which can be a novel pleiotropic marker of chronic disease risk (Aslibekyan et al., 2017). This evidence concerns the gene CPT1A and obesity due to melanocortin 4 receptor deficiency.